medline.ch Urologie-Nephrologie Tumoren BPH

	Treatment Patterns and Outcomes in Lymph-Node-Positive (pN1) Prostate Cancer: A National Cancer Database Study. Clin Genitourin Cancer Piccolini A, Korn SM, Qian Z, Brin P, Pohl K, Zurl H, Xiao B, Lughezzani G, Buffi NM, Nguyen PL, Sayan M, Trinh QD, Cole AP. PMID: 40883115 [PubMed - as supplied by publisher]
	Bladder Cancer: Role of Circular RNAs in Oncogenesis, Tumor Suppression, and Therapeutic Target Identification. Cancer Genomics Proteomics Nahkuri S, Weidle UH. PMID: 40883021 [PubMed - indexed for MEDLINE]
	Chinese Medicines as Therapeutic Options for Treating Prostate Cancer: Therapeutic Effects and Underlying Mechanisms. J Ethnopharmacol Li S, Jing S, Zhou J, Li H, Yin P, Zhang Q, Gong M, Zhao Y, Lu G, Jin G, Li X, Liang Y, Su L. PMID: 40882785 [PubMed - as supplied by publisher]
	Profiling autoantibodies at baseline and during immune checkpoint inhibitor therapy of renal cell carcinoma patients-exploratory results from TITAN-RCC. ESMO Open Fritzsch A, Leucht K, Röber N, Conrad K, Rothe R, Wehner R, Schumacher U, Esteban E, Barthélémy P, Schmidinger M, Schmitz M, Grimm MO. PMID: 40882246 [PubMed - as supplied by publisher]
	Reassessing the Evidence: Is Intensified Therapy Justified in Older Patients with Metastatic Hormone-Sensitive Prostate Cancer? Clin Genitourin Cancer Dottorini L, Sarno I, Iaculli A, Menna GD, Hussein Y, Vavassori I, Rossitto M, Luciani A, Petrelli F. PMID: 40882245 [PubMed - as supplied by publisher]
	Cardiovascular toxicity in testicular germ cell tumor survivors. Front Oncol Orszaghova Z, Mladosievicova B, Mego M, Chovanec M. PMID: 40881865 [PubMed - in process]
	Prognostic significance of systemic immunoinflammatory biomarkers in patients with clear cell renal cell carcinoma: a retrospective multicenter analysis. Front Immunol Chen D, Zhang Z, Dong L, Feng Z, Yang J. PMID: 40881716 [PubMed - indexed for MEDLINE]
	Analysis of standard vs dose-escalated stereotactic body radiation therapy in localized prostate cancer: a comparative evaluation of survival outcomes. Front Immunol Xu B, Zhao X, Wei T, Liang Y, Zhang W, Chen L, Lian Z, Zhang H. PMID: 40881703 [PubMed - indexed for MEDLINE]
	Elevated C-reactive protein and D-dimer to predict venous thromboembolism in patients with bladder cancer. Front Immunol Chen B, Zhang T, Wang Y, Li Z, Liu H, Jiang Z, Yang H, Cai Y, Fan G, Wang K, Zhang H, Hu H, Li Y. PMID: 40881698 [PubMed - indexed for MEDLINE]
	The United States Preventive Services Task Force (USPSTF) Guidelines vs. Electronic Health Record (EHR)-Based Screening: A Comparative Accuracy Study in Prostate Cancer. Cureus Lee KH, Alemi F, Wang X, Schwartz M. PMID: 40881554 [PubMed - in process]
	Mapping a New Blueprint of Multimodal Immunotherapy Against Prostate Cancer: Breakthroughs, Barriers, andÂ Bold Frontiers. FASEB J Wang Y, Cao F, Huang M, Teng Q, Guan Y, Pang J. PMID: 40880198 [PubMed - indexed for MEDLINE]
	Comparative neurological safety of novel hormonal therapies in advanced prostate cancer: a Bayesian network meta-analysis of randomized trials. Int J Clin Oncol Bushi G, Ullah A, Khan U, Sayyed H, Shabil M. PMID: 40880017 [PubMed - as supplied by publisher]
	Multi-regional Multiparametric Deep Learning Radiomics for Diagnosis of Clinically Significant Prostate Cancer. J Imaging Inform Med Liu X, Liu R, He H, Yan Y, Zhang L, Zhang Q. PMID: 40879858 [PubMed - as supplied by publisher]
	miRNA-mediated resistance mechanisms in prostate cancer: implications for targeted therapy and metastatic progression. Med Oncol Mostafa MM, El-Aziz MKA, Ellakwa DE. PMID: 40879856 [PubMed - indexed for MEDLINE]
	Dietary factors causally affect the risk of kidney cancer: a two-sample Mendelian randomization study. Discov Oncol Zhu C, Liu T, Jiang Z, Wang H, Zhang M, Sun W, Yan Z. PMID: 40879705 [PubMed - in process]
	Reduced recurrence of prostate cancer with novel autologous cancer vaccine (FK- PC101) post-prostatectomy: long-term results from a single-center phase 1/2 study. Future Sci OA Freitas DMO, Stein AC, Berger M, Kreutz FT. PMID: 40878915 [PubMed - in process]
	Relationship Between Prostate Cancer and Benign Hyperplasia: Role of Inflammation-Induced Oxidative Stress, Vitamin C, and Epigenetics. World J Mens Health Zarakowska E, Guz J, Gackowski D, Olinski R. PMID: 40878118 [PubMed - as supplied by publisher]
	Construction of lactylation (LA) risk signature in prostate cancer based on 4D fast DIA L-lactated quantitative genomics. J Transl Med Zou F, Jin Y, Zhang Z, Zhang Y, Wang M, Zhu F, Qiu J, Ye H, Fu Y, Ping H. PMID: 40877920 [PubMed - indexed for MEDLINE]
	Serum neopterin and kynurenine as predictive and prognostic biomarkers in prostate cancer: the role of dietary inflammatory index and biomarker interactions. BMC Cancer Icer MA, Koçak T, Acar-Tek N, Yesil S, Icer Y. PMID: 40877809 [PubMed - indexed for MEDLINE]
	Accuracy of Contrast-enhanced CT in Diagnosing Small-sized cT3a Renal Cell Carcinoma and Analysis of Factors Predicting Downstaging to pT1. In Vivo Bekku K, Yoshinaga K, Inoue S, Mitsui Y, Yamanoi T, Kawada T, Tominaga Y, Sadahira T, Katayama S, Iwata T, Nishimura S, Edamura K, Kobayashi T, Araki M. PMID: 40877189 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 179104

Seite 1 von 8956



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung